Cohance Lifesciences Ltd
Cohance Lifesciences's GHG Emissions Data Preview
In 2024, Cohance Lifesciences completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Cohance Lifesciences has also provided a category-level breakdown for 7 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Cohance Lifesciences's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Cohance Lifesciences amounted to 65,674 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Cohance Lifesciences decreased by 20.22%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Cohance Lifesciences's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Cohance Lifesciences's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Cohance Lifesciences were 41,259 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Cohance Lifesciences reduced its Scope 1 emissions over time?
Since 2022, Cohance Lifesciences's Scope 1 emissions have decreased by 13.13%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Cohance Lifesciences's Scope 1 emissions decreased by 15.09%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
What are Cohance Lifesciences's Scope 2 emissions?
In 2024, Cohance Lifesciences reported Scope 2 greenhouse gas (GHG) emissions of 24,415 tCOâ‚‚e without specifying the calculation method.
Has Cohance Lifesciences reduced its Scope 2 emissions over time?
Since 2022, Cohance Lifesciences's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 31.15%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Cohance Lifesciences's Scope 2 emissions (Unspecified Calculation Method) fell by 27.6% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.
What methodology does Cohance Lifesciences use for Scope 2 reporting?
In 2024, Cohance Lifesciences reported its Scope 2 emissions using an unspecified methodology.
Cohance Lifesciences's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Cohance Lifesciences's Value Chain Emissions
In 2024, Cohance Lifesciences reported 52,639.57 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Cohance Lifesciences includes a breakdown across 7 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chain
Cohance Lifesciences's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Cohance Lifesciences's Scope 3 emissions?
In 2024, Cohance Lifesciences reported total Scope 3 emissions of 52,639.57 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment.
What categories of Scope 3 emissions does Cohance Lifesciences disclose?
In 2024, Cohance Lifesciences reported emissions for 7 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Cohance Lifesciences's Scope 3 emissions?
In 2024, the largest contributors to Cohance Lifesciences's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 32,337.4 tCOâ‚‚e (61.43%)
- Fuel- and Energy-Related Services (Cat. 3): 10,424.42 tCOâ‚‚e (19.8%)
- Waste Generated in Operations (Cat. 5): 4,345.36 tCOâ‚‚e (8.25%)
Cohance Lifesciences's Scope 3 Emissions by Categories
Insights into Cohance Lifesciences's Total Carbon Footprint
In 2024, Cohance Lifesciences reported a total carbon footprint of 118,313.57 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 43.73% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.
The largest contributor to Cohance Lifesciences's total carbon footprint was Scope 3 emissions, accounting for 44.49% of the company's total carbon footprint, followed by Scope 1 emissions at 34.87%.